by Surgical Procedures amid Coronavirus Pandemic
The coronavirus pandemic has put intense pressure on the healthcare system across the globe. With shortage of hospital beds, medical staff, and necessary protective equipment required for elective surgical processes, healthcare practitioners gave priority to critical patients suffering from severe health complications. Considering risk and safety of patients, non-emergency surgeries have been cancelled or postponed in the time of rapidly spreading coronavirus. This factor has negatively affected the post-operative pain therapeutics market. However, the post-operative pain therapeutics market is booming after the significant efforts taken by governments, healthcare practitioners, and market stakeholders to recover from losses caused due to the pandemic. Increasing geriatric population suffering from chronic pain, rising surgical procedures, and rapidly improving post-operative pain management treatments are some of the factors responsible for the global market growth.
Get the sample copy of report@ https://qyresearchmedical.com/sample/111788
Innovations in Pain Management, Drug Discovery, and Development
Increasing investments in developing drugs and medications required for the post-operative pain relief and implementing the artificial intelligence (AI) technology in drug discovery platforms are boosting the global post-operative pain therapeutics market. Advanced technology, along with increasing research and development activities in the drug discovery and development field positively contributes to market expansion. Expanding online and offline distribution channels, hospitals, pharmacies, etc. help grow small and medium-scale manufacturers to mark their presence in global market. Manufacturers are focusing on the production of novel drugs to cater to the increasing demand from healthcare centers.
Awareness about Surgical Treatments Creating Profitable Avenues
The post-operative pain therapeutics market is expected to expand at a CAGR of 5.7% during the forecast period of 2021-2031. The global market is projected to cross US$ 19.6 Bn by 2031. Factors such as increasing awareness of surgical procedures with advanced technology, improvement in healthcare infrastructure, and rising investments in healthcare by governments are driving the global post-operative pain therapeutics market, creating tremendous opportunities for market players. Growing prevalence of cancer, increasing incidences of other cardiovascular surgeries across the globe, and advancements in treatments after the surgical procedures are escalating the demand for post-operative pain therapeutics. In order to minimize the post-operative adverse effects of surgeries, healthcare professionals and pharmaceutical players are introducing pain relief drugs, opioids, NSAIDs, and local anesthetics.
Advancements in Disease Diagnosis Procedures and Treatments
Market players in the healthcare industry are collaborating for exploring newest technologies and trends for disease diagnosis and treatments for severe health complications. The market is projected to witness lucrative growth opportunities during the forecast period, owing to the increasing geriatric population, rapid technological advancements, and favorable government policies. Countries are taking a steps to spread awareness about the different surgical procedures available in healthcare centers, and taking care of pain management treatments to avoid further risks. Moreover, high prevalence of chronic diseases demands for executing surgical procedures, which directly contribute to the market growth.
Asia Pacific Offers Lucrative Growth Opportunities
Asia Pacific offers lucrative growth opportunities for players in the post-operative pain therapeutics market due to growing geriatric population, advancements in healthcare and pharmaceutical industries, and increasing number of surgical procedures. Asian countries such as China and India are likely to dominate the market due to its rapidly developing healthcare infrastructure. Rising investments in research and development of pain-relief drugs in the region are likely to boost market growth. In addition, increasing awareness and promotional activities by governments to introduce pain management therapeutics to patients also creates opportunities for the post-operative pain therapeutics market players in Asia Pacific.
Analysts’ Viewpoint
Research and development in drug discovery platforms and collaborative efforts of healthcare professionals and government to introduce effective strategies in post operative pain management are driving the global post-operative pain therapeutics market amid the coronavirus pandemic. Companies in the post-operative pain therapeutics market can accelerate their product development and unlock revenue opportunities to obtain competitive benefits.
Market stakeholders are extending their services arms to gain a competitive edge. Increasing incidences of cardiovascular, neurological disorders, diabetes, rising surgical procedures, and rising accidental cases are boosting the demand for post-operative pain therapeutics. Players in the post-operative pain therapeutics market should focus on effective and cost-efficient treatments for patients.
Post-operative Pain Therapeutics Market: Overview
This report analyzes the current scenario and future prospects of the global post-operative pain therapeutics market. The rising prevalence of various diseases across the world, as well as an increase in the geriatric patient pool, are the key factors projected to drive the global generic injectable market during the forecast period.
The report provides an elaborate executive summary, including a snapshot of various segments of the global post-operative pain therapeutics market. It also provides elaborate information and data analysis of the global post-operative pain therapeutics market with regard to segments based on drug class, route of administration, distribution channel, and region.
The overview section of the report provides a detailed qualitative analysis of the drivers and restraints, and opportunities that affect the global post-operative pain therapeutics market
Additionally, the report includes company profiles, which provide information about their business, product portfolios, and competitive landscape in the post-operative pain therapeutics market
The report on the global post-operative pain therapeutics market offers market attractiveness analysis of the regions and segments
The last section of the report comprises quantitative and qualitative analysis on market share/position of key players operating in the global post-operative pain therapeutics market. It analyzes the key competitive strategies adopted by the major industry players, thereby presenting a thorough understanding of the competitive scenario in the global post-operative pain therapeutics market.
Post-operative Pain Therapeutics Market: Key Segments
In terms of drug class, the global post-operative pain therapeutics market has been classified into opioids, NSAIDS, local anesthetics, tricyclic antidepressants, antiepileptic drugs, and others. The opioids segment accounted for major share of the global post-operative pain therapeutics market in 2020 and the trend is anticipated to continue during the forecast period.
Based on route of administration, the global post-operative pain therapeutics market has been categorized into oral, intramuscular, intravenous, and others
In terms of distribution channel, the global post-operative pain therapeutics market has been divided into hospital pharmacies, retail pharmacies, online pharmacies, and others
The market value and forecast for each of these segments have been provided from 2017 to 2031. The CAGR of respective segments has also been provided from 2021 to 2031, considering 2017 to 2019 as the historical year and 2020 as the base year.
Post-operative Pain Therapeutics Market: Regional Outlook
In terms of region, the global post-operative pain therapeutics market has been segmented into North America (U.S. and Canada), Europe (U.K., Germany, Spain, Italy, France, and Rest of Europe), Asia Pacific (China, India, Japan, Australia & New Zealand, and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America), and Middle East & Africa (GCC Countries, South Africa, and Rest of Middle East & Africa). Each region considered in the market has been divided into countries/sub-regions.
The post-operative pain therapeutics market report provides value and forecast for each region and country/sub-region from 2017 to 2031. The compound annual growth rates (CAGRs) for each of these regions and countries have also been provided for the forecast period from 2021 to 2031. The post-operative pain therapeutics market study also covers the competitive scenario in these regions.
Companies Mentioned in Report
Key players in the global post-operative pain therapeutics market have been profiled based on attributes such as company overview, product portfolio, financial overview, recent developments, and competitive business strategies
Major companies profiled in the global post-operative pain therapeutics market report are
- Allergan plc
- Bayer AG
- Camarus
- Eli Lilly & Company
- Egalet Corporation
- Endo International plc
- Janssen Pharmaceuticals, Inc.
- GlaxoSmithKline plc
- Mallinckrodt Pharmaceuticals
- Mylan N.V.
- Novartis AG
- Pacira Pharmaceuticals, Inc.
- Pfizer, Inc.
- Purdue Pharma L.P
- Teva Pharmaceutical Industries Ltd.
- Trevena, Inc.
Key Questions Answered in Post-operative Pain Therapeutics Market Report
- What are the major drivers, restraints, and opportunities in the global market?
- What will be the revenue share projections of key segments of the global post-operative pain therapeutics market during the forecast period?
- Which segment is likely to lead the global post-operative pain therapeutics market in terms of revenue by 2031?
- How mergers & acquisitions among players are widening the scope of the global post-operative pain therapeutics market?
- Which are the leading companies in the global post-operative pain therapeutics market?
Post-operative Pain Therapeutics Market – Segmentation
Drug Class
- Opioids
- NSAIDS
- Local Anesthetics
- Tricyclic Antidepressants
- Antiepileptic Drugs
- Others
Route of Administration
- Oral
- Intramuscular
- Intravenous
- Others
Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Others
Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
Purchase Complete Report Now@ https://qyresearchmedical.com/report/checkout/111788/2900
